- Home
- GDST vs RVNC Comparison
GDST vs RVNC Comparison
Compare GDST & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDST
- RVNC
- Stock Information
- Founded
- GDST 2020
- RVNC 1999
- Country
- GDST United States
- RVNC United States
- Employees
- GDST N/A
- RVNC N/A
- Industry
- GDST
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- GDST
- RVNC Health Care
- Exchange
- GDST NYSE
- RVNC Nasdaq
- Market Cap
- GDST N/A
- RVNC 320.5M
- IPO Year
- GDST 2022
- RVNC 2014
- Fundamental
- Price
- GDST $11.29
- RVNC $3.09
- Analyst Decision
- GDST
- RVNC Hold
- Analyst Count
- GDST 0
- RVNC 9
- Target Price
- GDST N/A
- RVNC $8.45
- AVG Volume (30 Days)
- GDST 125.0
- RVNC 3.6M
- Earning Date
- GDST 01-01-0001
- RVNC 11-07-2024
- Dividend Yield
- GDST N/A
- RVNC N/A
- EPS Growth
- GDST 111.15
- RVNC N/A
- EPS
- GDST 0.23
- RVNC N/A
- Revenue
- GDST N/A
- RVNC $256,945,000.00
- Revenue This Year
- GDST N/A
- RVNC $11.28
- Revenue Next Year
- GDST N/A
- RVNC $27.21
- P/E Ratio
- GDST $49.87
- RVNC N/A
- Revenue Growth
- GDST N/A
- RVNC 25.82
- 52 Week Low
- GDST $10.73
- RVNC $2.30
- 52 Week High
- GDST $12.45
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- GDST 80.29
- RVNC 33.47
- Support Level
- GDST N/A
- RVNC $3.06
- Resistance Level
- GDST $11.31
- RVNC $3.09
- Average True Range (ATR)
- GDST 0.00
- RVNC 0.11
- MACD
- GDST 0.01
- RVNC 0.02
- Stochastic Oscillator
- GDST 81.82
- RVNC 6.90
About GDST GOLDENSTONE ACQUISITION LIMITED
Goldenstone Acquisition Ltd is a newly organized blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.